|
Volumn 3, Issue 8, 2001, Pages 572-574
|
Fixed-dose combination therapy in the United States, Britain and Israel
a a a |
Author keywords
Anti infective drugs; Cardiovascular drugs; Dermatological drugs; Fixed dose combination; Gastrointestinal drugs
|
Indexed keywords
CARDIOLOGY;
DERMATOLOGY;
DRUG PRODUCTS;
PHARMACEUTICAL COMPANIES;
DRUG THERAPY;
ANTIINFECTIVE AGENT;
CARDIOVASCULAR AGENT;
DERMATOLOGICAL AGENT;
GASTROINTESTINAL AGENT;
GENERIC DRUG;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG FORMULARY;
DRUG INDUSTRY;
DRUG INFORMATION;
GASTROINTESTINAL DISEASE;
GEOGRAPHIC DISTRIBUTION;
HUMAN;
INFECTION;
ISRAEL;
MAJOR CLINICAL STUDY;
OUTCOMES RESEARCH;
PHYSICIAN;
POPULATION RESEARCH;
SKIN DISEASE;
UNITED KINGDOM;
UNITED STATES;
DATA COLLECTION;
DRUG COMBINATIONS;
DRUGS, GENERIC;
DRUGS, NON-PRESCRIPTION;
GREAT BRITAIN;
HUMANS;
ISRAEL;
UNITED STATES;
|
EID: 0034823150
PISSN: 15651088
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (19)
|